Highlights and Quick Summary
- Income from Continuous Operations for the quarter ending September 30, 2022 was $-1.22 Million (a 159.81% increase compared to previous quarter)
- Year-over-year quarterly Income from Continuous Operations decreased by -100.28%
- Annual Income from Continuous Operations for 2021 was $-1.61 Million (a -11.73% decrease from previous year)
- Annual Income from Continuous Operations for 2020 was $-1.82 Million (a -46.72% decrease from previous year)
- Twelve month Income from Continuous Operations ending September 30, 2022 was $429 Million (a -0.17% decrease compared to previous quarter)
- Twelve month trailing Income from Continuous Operations decreased by -0.22% year-over-year
Trailing Income from Continuous Operations for the last four month:
| 30 Sep '22 | 30 Jun '22 | 31 Mar '22 | 31 Dec '21 |
|---|---|---|---|
| $429 Million | $429 Million | $429 Million | $430 Million |
Visit stockrow.com/BBLG
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Income from Continuous Operations of Bone Biologics Corp.
Most recent Income from Continuous Operationsof BBLG including historical data for past 10 years.Interactive Chart of Income from Continuous Operations of Bone Biologics Corp.
Bone Biologics Corp. Income from Continuous Operations for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | $-1.22 | $-0.47 | $-0.69 | – |
| 2021 | $431.14 | $-0.51 | $-0.49 | $-0.43 | $-1.61 |
| 2020 | – | – | – | – | $-1.82 |
| 2019 | – | – | – | – | $-3.42 |
Business Profile of Bone Biologics Corp.
Sector: Healthcare
Industry: Medical Devices